new capit deploy take price
remain overweight rate share follow disclosur new
capit alloc plan unexpect somewhat alarm mid-day trade
halt announc board-approv plan deploy capit follow us tax
reform includ addit share repurchas author
dividend increas incorpor model increas price target
would remain buyer share
new capit alloc plan larg presag recal report
result week ago manag indic capit deploy plan
respons tax reform work pend board approv
rais share buy-back part new plan abbv board author
new share repurchas program note end
compani remain exist program first author
februari doesnt appear acceler repurchas unlik amgn
recently-disclos dutch auction tender offer remain seen quickli
commenc effort
dividend yield shabbi concurr increas quarterli
cash dividend per share per share step put
dividend yield impress comparison amgn
rais target roughli repurchas author share price
translat share today price compar share outstand
assum share price appreci model full author
use repurchas share exact
time remain unclear us price target base ep estim
less impact target bring ep estim
respect price target deriv appli unchang
multipl adjust ep discount back thu increas
trial failur key drug deterior price outlook unexpect patent loss
brand pharmaceut compani key product span inflammatori
diseas oncolog virolog well specialist area
ep discount back
year
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
good sold
product sale
total revenu
sell gener administr
total revenu
statement oper
dollar except per share data
provis incom tax tax benefit
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
